Long-lasting remission in de novo breast myeloid sarcoma treated with decitabine and radiotherapy

Carla Minoia; Vincenza de Fazio; Giovanni Scognamillo; Anna Scattone; Nicola Maggialetti; Cristina Ferrari; Attilio Guarini

doi:10.3390/diagnostics9030084

Long-lasting remission in de novo breast myeloid sarcoma treated with decitabine and radiotherapy

Carla Minoia, Vincenza de Fazio, Giovanni Scognamillo, Anna Scattone, Nicola Maggialetti, Cristina Ferrari, Attilio Guarini

Research output: Contribution to journal › Article › peer-review

Abstract

Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.

Original language	English
Article number	84
Journal	Diagnostics
Volume	9
Issue number	3
DOIs	https://doi.org/10.3390/diagnostics9030084
Publication status	Published - Sep 1 2019

Keywords

Acute myeloid
Breast
Decitabine
Extramedullary
Leukemia
Myeloid
Sarcoma

ASJC Scopus subject areas

Clinical Biochemistry

Access to Document

10.3390/diagnostics9030084

Fingerprint Dive into the research topics of 'Long-lasting remission in de novo breast myeloid sarcoma treated with decitabine and radiotherapy'. Together they form a unique fingerprint.

Cite this

@article{2d74f2ca12aa43f6bfc08c1c2d5ea810,

title = "Long-lasting remission in de novo breast myeloid sarcoma treated with decitabine and radiotherapy",

abstract = "Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.",

keywords = "Acute myeloid, Breast, Decitabine, Extramedullary, Leukemia, Myeloid, Sarcoma",

author = "Carla Minoia and {de Fazio}, Vincenza and Giovanni Scognamillo and Anna Scattone and Nicola Maggialetti and Cristina Ferrari and Attilio Guarini",

year = "2019",

month = sep,

day = "1",

doi = "10.3390/diagnostics9030084",

language = "English",

volume = "9",

journal = "Diagnostics",

issn = "2075-4418",

publisher = "MDPI AG",

number = "3",

}

TY - JOUR

T1 - Long-lasting remission in de novo breast myeloid sarcoma treated with decitabine and radiotherapy

AU - Minoia, Carla

AU - de Fazio, Vincenza

AU - Scognamillo, Giovanni

AU - Scattone, Anna

AU - Maggialetti, Nicola

AU - Ferrari, Cristina

AU - Guarini, Attilio

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.

AB - Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.

KW - Acute myeloid

KW - Breast

KW - Decitabine

KW - Extramedullary

KW - Leukemia

KW - Myeloid

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=85072598188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072598188&partnerID=8YFLogxK

U2 - 10.3390/diagnostics9030084

DO - 10.3390/diagnostics9030084

M3 - Article

AN - SCOPUS:85072598188

VL - 9

JO - Diagnostics

JF - Diagnostics

SN - 2075-4418

IS - 3

M1 - 84

ER -